Your browser doesn't support javascript.
loading
Blocking CDK1/PDK1/ß-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma.
Wu, Chuan Xing; Wang, Xiao Qi; Chok, Siu Ho; Man, Kwan; Tsang, Simon Hing Yin; Chan, Albert Chi Yan; Ma, Ka Wing; Xia, Wei; Cheung, Tan To.
Afiliación
  • Wu CX; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Wang XQ; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Chok SH; Department of Medicine, The University of Hong Kong, Hong Kong.
  • Man K; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Tsang SHY; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Chan ACY; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Ma KW; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Xia W; Department of Surgery, The University of Hong Kong, Hong Kong.
  • Cheung TT; Department of Surgery, The University of Hong Kong, Hong Kong.
Theranostics ; 8(14): 3737-3750, 2018.
Article en En | MEDLINE | ID: mdl-30083256

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Quinolinas / Tiazoles / Transducción de Señal / Carcinoma Hepatocelular / Inhibidores Enzimáticos / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Idioma: En Revista: Theranostics Año: 2018 Tipo del documento: Article País de afiliación: Hong Kong

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Quinolinas / Tiazoles / Transducción de Señal / Carcinoma Hepatocelular / Inhibidores Enzimáticos / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Idioma: En Revista: Theranostics Año: 2018 Tipo del documento: Article País de afiliación: Hong Kong